
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Columbia University, The Joseph L. Mailman School of Public Health, Division of Epidemiology, New York, New York 10032 [M. D. G., M. B. T.]; Columbia College of Physicians and Surgeons, Department of Pathology, New York, New York 10032 [H. H., S. B.]; New Jersey State Department of Health and Senior Services, Applied Cancer Epidemiology Program, Trenton, New Jersey 08625 [J. B. S.]; National Cancer Institute, Division of Cancer Epidemiology and Genetics, Bethesda, Maryland 20892 [L. A. B.]; Mt. Sinai Medical Center, Department of Community and Preventive Medicine, New York, New York 10029 [J. L. B.]; and University of Southern Maine, Department of Applied Sciences, Portland, Maine 04103 [W. D. T.]
p53 mutations may be a fingerprint for cigarette smoking and other environmental carcinogens, including breast carcinogens. This study was undertaken to explore whether p53 mutations are associated with environmental or other suspected or established risk factors for breast cancer. p53 protein detection by immunohistochemistry (which is more easily quantified in large epidemiological studies than are mutations, and are highly correlated with them) was determined for 378 patients from a case-control study of breast cancer. In this population-based sample of women under the age of 45 years, 44.4% (168/378) of the cases had p53 protein detected by immunohistochemistry (p53+). Polytomous logistic regression was used to calculate the odds ratios (ORs) for p53+ and p53- breast cancer, as compared with the controls, in relation to cigarette smoking and other factors. The ratio of the ORs was used as an indicator of heterogeneity in risk for p53+ versus p53- cancer. The ratio of the ORs in a multivariate model was substantially elevated among women with a greater than high school education [2.39; 95% confidence interval (CI), 1.434.00], current cigarette smokers (1.96; 95% CI, 1.103.52), and users of electric blankets, water beds, or mattresses (1.78; 95% CI, 1.112.86). Nonsignificant heterogeneity was noted for family history of breast cancer and ethnicity but not for other known or suspected risk factors. Coupled with the strong biological plausibility of the association, our data support the hypothesis that in breast cancer, as with other tumors, p53 protein immunohistochemical detection may be associated with exposure to environmental carcinogens such as cigarette smoking.
This article has been cited by other articles:
![]() |
L. E. Mechanic, R. C. Millikan, J. Player, A. R. de Cotret, S. Winkel, K. Worley, K. Heard, K. Heard, C.-K. Tse, and T. Keku Polymorphisms in nucleotide excision repair genes, smoking and breast cancer in African Americans and whites: a population-based case-control study Carcinogenesis, July 1, 2006; 27(7): 1377 - 1385. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rundle Molecular Epidemiology of Physical Activity and Cancer Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 227 - 236. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Freudenheim, M. Bonner, S. Krishnan, C. B. Ambrosone, S. Graham, S. E. McCann, K. B. Moysich, E. Bowman, T. Nemoto, and P. G. Shields Diet and alcohol consumption in relation to p53 mutations in breast tumors Carcinogenesis, June 1, 2004; 25(6): 931 - 939. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Reynolds, S. Hurley, D. E. Goldberg, H. Anton-Culver, L. Bernstein, D. Deapen, P. L. Horn-Ross, D. Peel, R. Pinder, R. K. Ross, et al. Active Smoking, Household Passive Smoking, and Breast Cancer: Evidence From the California Teachers Study J Natl Cancer Inst, January 7, 2004; 96(1): 29 - 37. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Zhu, S. Hunter, K. Payne-Wilks, C. L. Roland, and D. S. Forbes Use of Electric Bedding Devices and Risk of Breast Cancer in African-American Women Am. J. Epidemiol., October 15, 2003; 158(8): 798 - 806. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. Terry and T. E. Rohan Cigarette Smoking and the Risk of Breast Cancer in Women: A Review of the Literature Cancer Epidemiol. Biomarkers Prev., October 1, 2002; 11(10): 953 - 971. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Terry, M. D. Gammon, J. B. Schoenberg, L. A. Brinton, N. Arber, and H. Hibshoosh Oral Contraceptive Use and Cyclin D1 Overexpression in Breast Cancer among Young Women Cancer Epidemiol. Biomarkers Prev., October 1, 2002; 11(10): 1100 - 1103. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Furberg, R. C. Millikan, J. Geradts, M. D. Gammon, L. G. Dressler, C. B. Ambrosone, and B. Newman Environmental Factors in Relation to Breast Cancer Characterized by p53 Protein Expression Cancer Epidemiol. Biomarkers Prev., September 1, 2002; 11(9): 829 - 835. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Gammon, R. M. Santella, A. I. Neugut, S. M. Eng, S. L. Teitelbaum, A. Paykin, B. Levin, M. B. Terry, T. L. Young, L. W. Wang, et al. Environmental Toxins and Breast Cancer on Long Island. I. Polycyclic Aromatic Hydrocarbon DNA Adducts Cancer Epidemiol. Biomarkers Prev., August 1, 2002; 11(8): 677 - 685. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Conway, S. N. Edmiston, L. Cui, S. S. Drouin, J. Pang, M. He, C.-K. Tse, J. Geradts, L. Dressler, E. T. Liu, et al. Prevalence and Spectrum of p53 Mutations Associated with Smoking in Breast Cancer Cancer Res., April 1, 2002; 62(7): 1987 - 1995. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Daling, K. E. Malone, D. R. Doody, B. O. Anderson, and P. L. Porter The Relation of Reproductive Factors to Mortality from Breast Cancer Cancer Epidemiol. Biomarkers Prev., March 1, 2002; 11(3): 235 - 241. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rundle, D. Tang, J. Zhou, S. Cho, and F. Perera The Association between Glutathione S-Transferase M1 Genotype and Polycyclic Aromatic Hydrocarbon-DNA Adducts in Breast Tissue Cancer Epidemiol. Biomarkers Prev., October 1, 2000; 9(10): 1079 - 1085. [Abstract] [Full Text] |
||||
![]() |
A. Morabia, M. S. Bernstein, I. Bouchardy, J. Kurtz, and M. A. Morris Breast Cancer and Active and Passive Smoking: The Role of the N-Acetyltransferase 2 Genotype Am. J. Epidemiol., August 1, 2000; 152(3): 226 - 232. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rundle, D. Tang, H. Hibshoosh, A. Estabrook, F. Schnabel, W. Cao, S. Grumet, and F. P. Perera The relationship between genetic damage from polycyclic aromatic hydrocarbons in breast tissue and breast cancer Carcinogenesis, July 1, 2000; 21(7): 1281 - 1289. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Thompson and C. Ambrosone Chapter 7: Molecular Epidemiology of Genetic Polymorphisms in Estrogen Metabolizing Enzymes in Human Breast Cancer J Natl Cancer Inst Monographs, July 1, 2000; 2000(27): 125 - 134. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. THOMPSON Abreast of the West: German effort to distract Poles from the truth about smoking Tob. Control, March 1, 2000; 9(1): 102 - 103. [Full Text] [PDF] |
||||
![]() |
M. D. Gammon, H. Hibshoosh, M. B. Terry, S. Bose, J. B. Schoenberg, L. A. Brinton, J. L. Bernstein, and W. D. Thompson Oral Contraceptive Use and Other Risk Factors in Relation to HER-2/neu Overexpression in Breast Cancer Among Young Women Cancer Epidemiol. Biomarkers Prev., May 1, 1999; 8(5): 413 - 419. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |